Log on / register
Feedback | Support | My details
NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.
Bratasz A, Selvendiran K, Wasowicz T, Bobko A, Khramtsov VV, Ignarro LJ, Kuppusamy P
J Transl Med 2008, 6:9
[Full text] [PubMed] [Related articles]


No citations for this article were found in PubMed Central.


You can also check ISI Web of Science for additional citations (subscription required)
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.